Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SB | NMM |
|---|---|---|
| Price | $8.45 | $90.78 |
| Change today | ▼ 1.52% | ▼ 0.66% |
| Market cap | $961.89M | $2.63B |
| Return, 3 months | +27.4% | +23.2% |
| Return, year to date | +80.2% | +73.4% |
| Return, 1 year | +99.2% | +103.6% |
| P/E (TTM) | 11.0 | 5.9 |
| P/B | 1.1 | -4,539.0 |
| P/E percentile vs own 5y | 84th | 86th |
| Dividend yield | 2.49% | 0.23% |
| Revenue growth (YoY, latest qtr) | +33.0% | +25.2% |
| Net profit growth (YoY) | +1,970.5% | +140.1% |
| Gross margin | 44.2% | 40.5% |
| Operating margin | 33.3% | 34.1% |
| Net margin | 25.7% | 29.6% |
| Return on equity | 9.4% | 27.5% |
| Analyst target vs. price | – | +10.2% |
| Analyst buy share | – | 100% |
| RSI (14) | 49 | 53 |
| 30-day volatility | 42.6% | 30.4% |
| Max drawdown, 1 year | -14.7% | -18.7% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
